IntelGenx Technologies Corp (IGXT)

[killers_420]

Forfivo sales are still weak obviously, but I did notice a slight difference in the language they use to describe the situation.

From 1Q 10Q - Royalty income in the second quarter of 2013 is expected to be lower than royalty income achieved in the current quarter, as a result of lower than anticipated sales of Forfivo XL™ during the current quarter. Management is assessing this variation in sales performance with a view towards taking steps to support steady sales growth of Forfivo XL™.

From 2Q10Q - Sales levels achieved for Forfivo XL™, and related royalty income, have been lower than anticipated in the first six months of 2013. Management is actively taking steps to accelerate sales growth of Forfivo XL™.

At least they updated this to state they are actively taking steps to accelerate growth, as opposed to just "assessing this variation".

Not sure what their plan is, but we shall see.